Treatment of haemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine and prednisone

Swiss Medical Weekly

Volumn 142, Issue FEBRUARY, 2012, Pages

  Hu, Yixin ^a   Xu, Ji ^a   Wang, Lingling ^a   Li, Jianyong ^a   Qiu, Hongxia ^a   Zhang, Sujiang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

COP regimen; Haemophagocytic lymphohistiocytosis; Secondary aetiology

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INFECTION; LYMPHOMA; MALE; TREATMENT RESPONSE; BIOPSY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG COMBINATION; HOSPITALIZATION; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPSY; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 84858266275     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2012.13512     Document Type: Article

References (25)

1. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-31. (Pubitemid 44958267)
2. Szyper-Kravitz M. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm. Isr Med Assoc J. 2009;11:633-4.
3. Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010; 6:137-54.
4. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997; 89:794-800. (Pubitemid 27121272)
5. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-produing macrophage. Blood. 2005;105:1648-51. (Pubitemid 40223686)
6. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58-65. (Pubitemid 47204491)
7. Blanche S, Caniglia M, Girault D, Landman J, Griscelli C, Fischer A. Treatment of hemophagocytic lymphohistiocytosis with 22 cases of chemotherapy and bone marrow transplantation: a single-center study. Blood. 1991;78:51-4.
8. Cesaro S, Locatelli F, Lanino E, Porta F, Di Maio L, Messina C, et al. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP). Haematologica. 2008;93:1694-701.
9. Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J, et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood. 2005;105:1417-23. (Pubitemid 40223656)
10. Wang SH, Wang QS, Sun L, Li HH, Zhao Y, Jia BJ, et al. Clinical analysis of 12 patients with angioimmunoblastic T cell lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010;18:1208-10.
11. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009:127-31.
12. Okamoto M, Yamaguchi H, Isobe Y, Yokose N, Mizuki T, Tajika K, et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med. 2009;48:775-81.
13. Henter JI, Samuelsson Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367-73.
14. Nizar Mahlaoui, Marie Ouachée-Chardin, Geneviève de Saint Basile, Bénédicte. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: A single-center retrospective report of 38 patients. Pediatrics. 2007;120:622-8.
15. Shin HJ, Chung JS, Lee JJ, Sohn SK, Choi YJ, Kim YK, et al. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. J Korean Med Sci. 2008;23:439-44.
16. Imshuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001;19:2665-73. (Pubitemid 32441371)
17. Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol. 2007;19:477-81. (Pubitemid 47344241)
18. Stéphan JL, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology. (Oxford) 2001;40:1285-92.
19. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly. 2005;135:299-314. (Pubitemid 40942436)
20. Balwierz W, Czogała M, Czepko E. Anaplastic large cell lymphoma associated with hemophagocytic lymphohistiocytosis: a case report and review of the literature. Przegl Lek. 2010;67:436-8.
21. Zhu Y, Gao Y, Zhu XH, Chen XY. Diagnosis and treatment of hemophagocytic lymphohistiocytosis in children with HLH-2004 protocol. J Clin Pediatr. 2009;27:718-22.
22. Thompson PA, Allen CE, Horton T, Jones JY, Vinks AA, McClain KL. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2009;52:621-5.
23. Escoto H, Ringewald J, Kalpatthi R. Etoposide-related cardiotoxicity in a child with haemophagocytic lymphohistiocytosis. Cardiol Young. 2010;20:105-7.
24. Seo YI, Park R, Choi TY, Shin JW, Won JH, Park HS, et al. A case of therapy-related acute monocytic leukemia following low-dose of etoposide treatment for hemophagocytic lymphohistiocytosis. Korean J Lab Med. 2007;27:244-7.
25. Zhang LJ, Qiu HX, Li JY, Xu J, Wang LL, Hu YX, et al. Clinical analysis of 10 cases of secondary hemophagocytic lymphohistiocytosis treated with HLH-2004 chemotherapy. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010;18:1525-30.